Location History:
- New York, NY (US) (2012)
- München, DE (2019)
- Munich, DE (2013 - 2021)
Company Filing History:
2 out of 14 
2 out of 1,627 
Years Active: 2012-2021
Title: Florian Bassermann: Innovator in Immunomodulatory Treatments
Introduction
Florian Bassermann is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunomodulatory treatments, holding a total of 4 patents. His work focuses on enhancing the efficacy of immunomodulatory imide drugs (IMiDs) in treating various diseases.
Latest Patents
One of Florian's latest patents is a method for assessing the efficacy of IMiDs and a composition or combination for use in treating IMiD sensitive diseases. This invention involves a combination of an IMiD and an inhibitor of CD147 and/or an inhibitor of MCT1 for treating diseases in subjects. It also addresses the treatment of patients who are IMiD resistant. Furthermore, the patent outlines a method for monitoring the efficacy of an IMiD treatment regimen by comparing the protein levels of CD147 and/or MCT1 in samples obtained from a subject before and during IMiD treatment.
Career Highlights
Florian has worked with prestigious institutions, including Klinikum Rechts Der Isar Der Technischen Universität München and New York University. His experience in these organizations has contributed to his expertise in the field of immunology and drug development.
Collaborations
Florian has collaborated with Michele Pagano, a fellow researcher, to advance the understanding and application of immunomodulatory treatments.
Conclusion
Florian Bassermann's innovative work in the field of immunomodulatory treatments showcases his dedication to improving patient outcomes through scientific research and collaboration. His contributions continue to influence the landscape of medical treatments for IMiD sensitive diseases.